This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Albert Einstein College of Medicine. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Mahantesh Navati: Innovator in Therapeutic Delivery Systems
Introduction
Mahantesh Navati is a prominent inventor based in the Bronx, NY. He has made significant contributions to the field of therapeutic delivery systems, particularly through his innovative patent that focuses on sol-gel and hydrogel technologies. His work aims to enhance drug delivery methods, making treatments more effective and versatile.
Latest Patents
Navati holds a patent for a "Sol-gel/hydrogel therapeutic delivery system and methods thereof." This patent discloses a delivery platform designed for the preparation of versatile sol-gel and hydrogel-based nano and micro particles. These particles can be loaded with small molecules and are suitable for various drug delivery methods, including topical, transdermal, intravenous (IV), intraperitoneal (IP), and aerosol applications. The patent outlines methods of treatment utilizing these innovative particles, showcasing Navati's commitment to advancing medical technology.
Career Highlights
Navati is affiliated with the Albert Einstein College of Medicine, where he continues to work on groundbreaking research in therapeutic delivery systems. His role at this esteemed institution allows him to collaborate with other experts in the field and contribute to the advancement of medical science.
Collaborations
Some of Navati's notable coworkers include Adam Friedman and Andrew Draganski. Their collaborative efforts in research and development further enhance the impact of their work in therapeutic delivery systems.
Conclusion
Mahantesh Navati is a key figure in the innovation of therapeutic delivery systems, with a focus on sol-gel and hydrogel technologies. His contributions through patents and collaborations are paving the way for more effective medical treatments.